Posts

Showing posts with the label Low-grade glioma market forecast

Low-Grade Glioma – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Image
 Low-grade gliomas, which include grade II astrocytomas, oligodendrogliomas, and oligoastrocytomas, represent a diverse group of primary brain tumors known for their diffuse and slow-growing nature. Among these, pediatric low-grade gliomas (pLGG) are notably slow-growing infiltrative brain tumors that frequently progress into a more malignant state. They are the most common type of brain tumor seen in children and can originate from glial cells, neuronal cells, or a combination of both. This diversity is reflected in the locations within the central nervous system where these tumors can develop and the varying treatment outcomes, mainly when complete surgical removal is impossible. Low-grade gliomas can be further classified into subgroups, including pilocytic, subependymal giant cell, pilomyxoid, and diffuse astrocytomas. Additionally, two cancer-predisposition syndromes, neurofibromatosis type 1 (NF1) and tuberous sclerosis complex, are associated with an increased occurrence of ...

Low-Grade Glioma – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2021 To 2032

Image
  Low-grade gliomas grade II astrocytomas, oligodendrogliomas, and oligoastrocytomas) are a diverse set of primary brain tumors characteristically diffuse and slow growing. Pediatric Low-grade gliomas (pLGG) are relatively slow-growing infiltrative primary brain tumors that almost invariably undergo malignant transformation, the most common brain tumours in children and can arise from glial cells, neuronal cells or both. This heterogeneity is also reflected in the wide range of anatomical locations of these tumours within the CNS as well as treatment outcomes, particularly when surgical resection is either incomplete or not feasible. Low-grade gliomas comprise several subgroups, including pilocytic, pilomyxoid, subependymal giant cell, and diffuse astrocytomas.  Two cancer-predisposition syndromes, neurofibromatosis type 1 (NF1) and tuberous sclerosis complex are associated with an increased frequency of pilocytic astrocytomas and subependymal giant cell astrocytomas, resp...

Low-grade glioma – Market outlook, Epidemiology, Competitive Landscape and Market Forecast Report – 2020 To 2030

Image
Low-grade gliomas grade II astrocytomas, oligodendrogliomas, and oligoastrocytomas) are a diverse set of primary brain tumors that are characteristically diffuse and slow growing. Pediatric Low-grade gliomas (pLGG) are relatively slow-growing infiltrative primary brain tumors that almost invariably undergo malignant transformation most common brain tumours in children and can arise from glial cells, neuronal cells or both. This heterogeneity is also reflected in the diverse range of anatomical locations of these tumours within the CNS and in treatment outcomes, especially if surgical resection is either incomplete or not feasible. Low-grade gliomas comprise several subgroups, including pilocytic, pilomyxoid, subependymal giant cell, and diffuse astrocytomas.  Two cancer-predisposition syndromes, neurofibromatosis type 1 (NF1) and tuberous sclerosis complex, are associated with an increased frequency of pilocytic astrocytomas and subependymal giant cell astrocytomas, respectively. E...